BRIEF-Windtree Announces Transformational Agreement To Acquire Revenue Generating Environmental Services Business-March 2024-www.financetom.com

BRIEF-Windtree Announces Transformational Agreement To Acquire Revenue Generating Environmental Services Business

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Windtree Announces Transformational Agreement To Acquire Revenue Generating Environmental Services Business

Jun 10, 2025 6:39 AM

June 10 (Reuters) - Windtree Therapeutics Inc ( WINT ):

* WINDTREE ANNOUNCES TRANSFORMATIONAL AGREEMENT TO ACQUIRE

REVENUE

GENERATING ENVIRONMENTAL SERVICES BUSINESS

* WINDTREE THERAPEUTICS INC ( WINT ) - REFOCUSED STRATEGY EXPECTED TO

GENERATE $12 MILLION IN REVENUE

* WINDTREE THERAPEUTICS INC ( WINT ) - TO BUY TITAN ENVIRONMENTAL

SERVICES

* WINDTREE THERAPEUTICS INC ( WINT ) - TO ISSUE PREFERRED SHARES AND

SECURE

DEBT FINANCING TO FUND DEAL

Source text:

Further company coverage:

Previous page： Why Is Department Store Chain Macy's Stock Getting Battered Today? Next page： Vertex Pharmaceuticals Gets Health Canada Approval for Expanded Trikafta Use in Cystic Fibrosis Treatment

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Why Is Department Store Chain Macy's Stock Getting Battered Today?

Jul 15, 2024

Macy’s, Inc. shares are trading lower after the company announced today that it has terminated discussions with Arkhouse Management Co. LP and Brigade Capital Management, LP, citing the proposal does not provide compelling value. The decision comes after months of engagement without reaching an actionable proposal with certainty of financing and compelling value. Macy’s Board and management team have engaged...

Vertex Pharmaceuticals Gets Health Canada Approval for Expanded Trikafta Use in Cystic Fibrosis Treatment

Jul 15, 2024

10:07 AM EDT, 07/15/2024 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) said Monday that Health Canada has approved Trikafta for treating patients aged 2 years and older with certain cystic fibrosis transmembrane conductance regulator, CFTR, gene mutations. The marketing authorization expands the use of the drug for cystic fibrosis patients with a mutation in the CFTR gene that is...

Entegris Insider Sold Shares Worth $2,175,000, According to a Recent SEC Filing

Jul 15, 2024

10:02 AM EDT, 07/15/2024 (MT Newswires) -- Daniel D. Woodland, President, Advanced Planarization Solutions Division, on July 11, 2024, sold 15,000 shares in Entegris ( ENTG ) for $2,175,000. Following the Form 4 filing with the SEC, Woodland has control over a total of 37,457 shares of the company, with 37,457 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1101302/000163003924000008/xslF345X03/wk-form4_1721051772.xml Price: 143.60, Change:...

RTX Unit Wraps Up F135 Engine Core Upgrade Preliminary Design Review

Jul 15, 2024

10:04 AM EDT, 07/15/2024 (MT Newswires) -- RTX's (RTX) Pratt & Whitney unit said Monday it has completed the F135 Engine Core Upgrade's preliminary design review, confirming the ECU's design is on schedule and surpassing expectations. The upgrade is expected to enhance engine durability and performance for all F-35 variants, with Pratt & Whitney and the F-35 Joint Program Office...